ZPK urged to create more fair competition

Published: 2009-10-20 06:58:00

Updated: 2009-10-20 06:58:00

Zuellig Pharma Korea (ZPK) should not interfere with its domestic wholesalers’ efforts to make direct dealing with multinational companies, the Korean Pharmaceutical Association (KPA) in October 25 statement.

The statement said that ZPK will have to make more fair completion with domestic whol...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK